NZ314800A - Sulphonamide-substituted chroman derivatives and their use as a medicament or a diagnostic - Google Patents

Sulphonamide-substituted chroman derivatives and their use as a medicament or a diagnostic

Info

Publication number
NZ314800A
NZ314800A NZ314800A NZ31480097A NZ314800A NZ 314800 A NZ314800 A NZ 314800A NZ 314800 A NZ314800 A NZ 314800A NZ 31480097 A NZ31480097 A NZ 31480097A NZ 314800 A NZ314800 A NZ 314800A
Authority
NZ
New Zealand
Prior art keywords
sulphonamide
medicament
diagnostic
chroman derivatives
substituted chroman
Prior art date
Application number
NZ314800A
Other languages
English (en)
Inventor
Hans Jochen Lang
Uwe Gerlach
Joachim Brendel
Heinrich Christian Englert
Heinz Goegelein
Max Hropot
Helmut Bohn
Andreas Herling
Andreas Busch
Rainer Greger
Original Assignee
Hoechst Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE19619614A external-priority patent/DE19619614A1/de
Priority claimed from DE1996139462 external-priority patent/DE19639462A1/de
Application filed by Hoechst Ag filed Critical Hoechst Ag
Publication of NZ314800A publication Critical patent/NZ314800A/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12—Antidiarrhoeals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/58—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4
    • C07D311/68—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4 with nitrogen atoms directly attached in position 4
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/58—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4
    • C07D311/70—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4 with two hydrocarbon radicals attached in position 2 and elements other than carbon and hydrogen in position 6

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrane Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
NZ314800A 1996-05-15 1997-05-13 Sulphonamide-substituted chroman derivatives and their use as a medicament or a diagnostic NZ314800A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19619614A DE19619614A1 (de) 1996-05-15 1996-05-15 Sulfonamid-substituierte Chromane, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament
DE1996139462 DE19639462A1 (de) 1996-09-26 1996-09-26 Sulfonamid-substituierte Chromane, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament

Publications (1)

Publication Number Publication Date
NZ314800A true NZ314800A (en) 1999-02-25

Family

ID=26025736

Family Applications (1)

Application Number Title Priority Date Filing Date
NZ314800A NZ314800A (en) 1996-05-15 1997-05-13 Sulphonamide-substituted chroman derivatives and their use as a medicament or a diagnostic

Country Status (23)

Country Link
EP (1) EP0807629B1 (enExample)
JP (1) JP4234798B2 (enExample)
KR (1) KR100547921B1 (enExample)
CN (1) CN1204134C (enExample)
AR (2) AR007115A1 (enExample)
AT (1) ATE260909T1 (enExample)
AU (1) AU711986B2 (enExample)
BR (1) BR9703161A (enExample)
CA (1) CA2205477A1 (enExample)
CZ (1) CZ149497A3 (enExample)
DE (1) DE59711352D1 (enExample)
DK (1) DK0807629T3 (enExample)
ES (1) ES2218617T3 (enExample)
HR (1) HRP970255B1 (enExample)
HU (1) HUP9700903A3 (enExample)
IL (1) IL120827A (enExample)
NO (1) NO315556B1 (enExample)
NZ (1) NZ314800A (enExample)
PL (1) PL191330B1 (enExample)
PT (1) PT807629E (enExample)
SK (1) SK283837B6 (enExample)
TR (1) TR199700369A2 (enExample)
TW (1) TW496866B (enExample)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ329200A (en) * 1996-12-16 1999-05-28 Hoechst Ag Sulphonamide substituted quinazoline, isoquinoline, quinoline or benzo[1,3-]oxazine derivatives and medicaments
DE19705133A1 (de) * 1997-02-11 1998-08-13 Hoechst Ag Sulfonamid-substituierte Verbindungen, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament
DE19706675A1 (de) * 1997-02-20 1998-08-27 Hoechst Ag Sulfonamid-substituierte Chromane, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament
EP0895994A3 (de) * 1997-08-05 1999-12-15 Hoechst Marion Roussel Deutschland GmbH Sulfonamid-substituierte Pyranopyridine, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament
DE19742509A1 (de) * 1997-09-26 1999-04-01 Hoechst Marion Roussel De Gmbh Sulfonamid-substituierte Chromane, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltende pharmazeutische Zubereitungen
DE19742508A1 (de) * 1997-09-26 1999-04-01 Hoechst Marion Roussel De Gmbh Sulfonamid-substituierte Chromane, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltende pharmazeutische Zubereitungen
DE19748469A1 (de) * 1997-11-03 1999-05-06 Hoechst Marion Roussel De Gmbh Sulfonamid-substituierte Benzopyranderivate, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament sowie sie enthaltende pharmazeutische Zubereitungen
JP2002523451A (ja) 1998-09-01 2002-07-30 ブリストル−マイヤーズ スクイブ カンパニー カリウムチャネル抑制剤および方法
DE19858253A1 (de) 1998-12-17 2000-06-21 Aventis Pharma Gmbh Verwendung von Inhibitoren des KQt1-Kanals zur Herstellung eines Medikaments zur Behandlung von Krankheiten, die durch Helminthen und Ektoparasiten hervorgerufen werden
US7368582B2 (en) 2003-10-17 2008-05-06 Solvay Pharmaceuticals Gmbh Amidomethyl-substituted 2-(4-sulfonylamino)-3-hydroxy-3,4-dihydro-2H-chromen-6-yl compounds, a process and intermediates for their production, and pharmaceutical compositions containing them
JP4840594B2 (ja) * 2004-03-23 2011-12-21 日産化学工業株式会社 抗不整脈薬としての３環性ベンゾピラン化合物
US7884109B2 (en) 2005-04-05 2011-02-08 Wyeth Llc Purine and imidazopyridine derivatives for immunosuppression
US7989459B2 (en) 2006-02-17 2011-08-02 Pharmacopeia, Llc Purinones and 1H-imidazopyridinones as PKC-theta inhibitors
US7902187B2 (en) 2006-10-04 2011-03-08 Wyeth Llc 6-substituted 2-(benzimidazolyl)purine and purinone derivatives for immunosuppression
TW200831104A (en) 2006-10-04 2008-08-01 Pharmacopeia Inc 6-substituted 2-(benzimidazolyl)purine and purinone derivatives for immunosuppression
TW200837064A (en) 2006-10-04 2008-09-16 Pharmacopeia Inc 8-substituted 2-(benzimidazolyl)purine derivatives for immunosuppression
AR076524A1 (es) * 2009-04-30 2011-06-15 Nissan Chemical Ind Ltd Forma cristalina de un compuesto de benzopirano triciclico y metodo de produccion de la misma
TWI583677B (zh) * 2012-09-21 2017-05-21 日本臟器製藥股份有限公司 香豆素衍生物
CN103012380B (zh) * 2013-01-10 2015-03-04 山东大学 一种色满类化合物及其制备方法与应用
JP6089055B2 (ja) * 2014-03-20 2017-03-01 日本臓器製薬株式会社 クマリン誘導体を含有する医薬
AR117169A1 (es) 2018-11-28 2021-07-14 Bayer Ag (tio)amidas de piridazina como compuestos fungicidas
JP7822960B2 (ja) 2020-05-06 2026-03-03 バイエル、アクチエンゲゼルシャフト 殺真菌性化合物としてのピリジン（チオ）アミド
CN115605462B (zh) 2020-05-12 2026-04-14 拜耳公司 作为杀真菌化合物的三嗪和嘧啶(硫代)酰胺
WO2021233861A1 (en) 2020-05-19 2021-11-25 Bayer Aktiengesellschaft Azabicyclic(thio)amides as fungicidal compounds
CN115697059A (zh) 2020-05-27 2023-02-03 拜耳公司 活性化合物组合
US20250064060A1 (en) 2021-11-03 2025-02-27 Bayer Aktiengesellschaft Bis(hetero)aryl thioether (thio)amides as fungicidal compounds

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3737195A1 (de) * 1987-11-03 1989-05-18 Bayer Ag Chromanderivate, verfahren zu ihrer herstellung und ihre verwendung in arzneimitteln
FR2639349B1 (fr) * 1988-11-23 1991-02-22 Sanofi Sa Nouveaux derives du chromane actifs sur le systeme nerveux central, leur procede de preparation et les compositions pharmaceutiques en contenant
US5104890A (en) * 1989-03-28 1992-04-14 Fujisawa Pharmaceutical Company, Ltd. Benzopyran derivatives and processes for preparation thereof

Also Published As

Publication number Publication date
AR010314A1 (es) 2000-06-07
CN1169429A (zh) 1998-01-07
KR19980024020A (ko) 1998-07-06
HU9700903D0 (en) 1997-07-28
KR100547921B1 (ko) 2006-10-19
NO972211L (no) 1997-11-17
BR9703161A (pt) 1998-09-29
PT807629E (pt) 2004-07-30
IL120827A (en) 2004-12-15
HRP970255B1 (en) 2003-10-31
AR007115A1 (es) 1999-10-13
SK60397A3 (en) 1998-02-04
CN1204134C (zh) 2005-06-01
JP4234798B2 (ja) 2009-03-04
TW496866B (en) 2002-08-01
HUP9700903A2 (hu) 1998-12-28
SK283837B6 (sk) 2004-03-02
PL191330B1 (pl) 2006-04-28
AU711986B2 (en) 1999-10-28
ES2218617T3 (es) 2004-11-16
TR199700369A2 (xx) 1997-12-21
DK0807629T3 (da) 2004-05-17
DE59711352D1 (de) 2004-04-08
JPH1067772A (ja) 1998-03-10
IL120827A0 (en) 1997-09-30
NO315556B1 (no) 2003-09-22
EP0807629B1 (de) 2004-03-03
CA2205477A1 (en) 1997-11-15
MX9703534A (es) 1997-11-29
PL319995A1 (en) 1997-11-24
HUP9700903A3 (en) 1999-03-01
HRP970255A2 (en) 1998-04-30
CZ149497A3 (en) 1997-12-17
NO972211D0 (no) 1997-05-14
AU2080697A (en) 1997-11-20
ATE260909T1 (de) 2004-03-15
HK1006640A1 (en) 1999-03-12
EP0807629A1 (de) 1997-11-19

Similar Documents

Publication Publication Date Title
ZA943047B (en) Human osteoclast-derived cathepsin
EP0879013A4 (en) MEDICAL GUIDE WIRE
ZA969211B (en) Substituted sulfonimidamides processes for their preparation their use as a medicament or diagnostic and medicament comprising them
NZ329176A (en) 2,5-dioxo-imidazolidine derivatives and medicaments
IL113872A0 (en) Tissue monitor
NZ321576A (en) 6-imidazol-1-ylmethyl-2-oxo-quinoline derivatives and medicaments
IL120827A0 (en) Sulfonamide-substituted chromans processes for their preparation their use as a medicament or diagnostic and medicament comprising them
IL114795A0 (en) N-benzylindole- and benmzopyrazole derivatives their preparation and use
NZ332309A (en) Alkylamino-benzothiazole and -benzoxazole derivatives and medicaments
AU2672795A (en) Benzopyrans and their use as therapeutic agents
IL120924A0 (en) Substituted 2-naphthoylguanidines process for their preparation their use as a medicament or diagnostic and medicaments containing them
EP0793441A4 (en) TONOMETER TO BE OPERATED BY THE PATIENT
NZ305898A (en) Taxoid derivatives and medicaments
GB9414157D0 (en) Medical use
IL120925A0 (en) Substituted 1-naphthoylguanidines process for their preparation their use as a medicament or diagnostic and medicaments containing them
AU6520198A (en) Quinolinomorphinane derivatives and medicinal use thereof
GB9617550D0 (en) Medical ice-pack
ZA954732B (en) Benzopyrans and their use as therapeutic agents
IL116980A0 (en) Substituted thiophenylsulfonylureas and -thioureas processes for their preparation their use as a medicament or diagnostic and medicament containing them
AU3300397A (en) Cyclin-c variants, and diagnostic and therapeutic uses thereof
ZA947865B (en) Human glactokinase
GB9601042D0 (en) Medical use
GB9714038D0 (en) Patients's chart
GB9606686D0 (en) Medical use
GB9626920D0 (en) Medical use

Legal Events

Date Code Title Description
RENW Renewal (renewal fees accepted)